Skip to main content

Andy Gonzalez

Vitreoretinal surgeon at Mann Eye Institute (Houston) and founder of Retinex, an AI-native EMR for ophthalmology.

Oct 8, 2026

7:33
But what do you see as some of the technical or practical challenges that are there now? We all feel them, but how, how have you viewed this?
7:41
Sure.
7:42
You know, in ophthalmology and vitreoretinal, there are some dominant platforms.
7:46
Everyone in this space knows them.
7:48
I don't wanna get into them specifically because, again, they're great companies run by great people.
7:53
They've served the specialty for a long time, so let's focus on the pitfalls and problems.
7:59
I don't personally believe their software is built for the era of AI and interoperability that we're now entering, and it's not just me saying this either.

20 MINS LATER

28:22
Uh, is there an approval process? What is it? And where are you in the corporate structure building, corp- team building at this point?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.